Market News

Northern Trust Cut Its Ugi New (UGI) Holding by $3.43 Million as Valuation Declined; As United Therapeutics Del (UTHR) Stock Price Declined, Guggenheim Capital Has Upped Stake

UGI Corporation (NYSE:UGI) Logo

Guggenheim Capital Llc increased its stake in United Therapeutics Corp Del (UTHR) by 14.02% based on its latest 2017Q4 regulatory filing with the SEC. Guggenheim Capital Llc bought 12,694 shares as the company’s stock declined 21.89% with the market. The institutional investor held 103,231 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $15.27M, up from 90,537 at the end of the previous reported quarter. Guggenheim Capital Llc who had been investing in United Therapeutics Corp Del for a number of months, seems to be bullish on the $4.64 billion market cap company. The stock increased 3.56% or $3.66 during the last trading session, reaching $106.56. About 266,303 shares traded. United Therapeutics Corporation (NASDAQ:UTHR) has declined 23.69% since May 15, 2017 and is downtrending. It has underperformed by 35.24% the S&P500.

Northern Trust Corp decreased its stake in Ugi Corp New (UGI) by 4.39% based on its latest 2017Q4 regulatory filing with the SEC. Northern Trust Corp sold 74,666 shares as the company’s stock declined 7.25% with the market. The institutional investor held 1.63M shares of the natural gas distribution company at the end of 2017Q4, valued at $76.30 million, down from 1.70 million at the end of the previous reported quarter. Northern Trust Corp who had been investing in Ugi Corp New for a number of months, seems to be less bullish one the $8.65B market cap company. The stock increased 0.12% or $0.06 during the last trading session, reaching $49.99. About 920,718 shares traded or 15.36% up from the average. UGI Corporation (NYSE:UGI) has declined 12.69% since May 15, 2017 and is downtrending. It has underperformed by 24.24% the S&P500.

Analysts await UGI Corporation (NYSE:UGI) to report earnings on August, 1. They expect $0.15 EPS, up 66.67% or $0.06 from last year’s $0.09 per share. UGI’s profit will be $25.97M for 83.32 P/E if the $0.15 EPS becomes a reality. After $1.69 actual EPS reported by UGI Corporation for the previous quarter, Wall Street now forecasts -91.12% negative EPS growth.

More notable recent UGI Corporation (NYSE:UGI) news were published by: Seekingalpha.com which released: “UGI Corporation 2018 Q2 – Results – Earnings Call Slides” on May 04, 2018, also Globenewswire.com with their article: “New Research Coverage Highlights Barnes & Noble, The Blackstone Group, Hill-Rom, UGI, Fortive, and LightPath …” published on April 19, 2018, Fool.com published: “Cold Weather Drives UGI Corp’s Earnings Higher” on May 03, 2018. More interesting news about UGI Corporation (NYSE:UGI) were released by: Seekingalpha.com and their article: “UGI Corp (UGI) CEO John Walsh on Q2 2018 Results – Earnings Call Transcript” published on May 05, 2018 as well as Businesswire.com‘s news article titled: “Consecutive Year of Annual Dividend Increases” with publication date: April 24, 2018.

Northern Trust Corp, which manages about $394.86 billion US Long portfolio, upped its stake in Baidu Inc (NASDAQ:BIDU) by 47,209 shares to 2.11 million shares, valued at $494.95M in 2017Q4, according to the filing. It also increased its holding in M/I Homes Inc (NYSE:MHO) by 21,948 shares in the quarter, for a total of 329,795 shares, and has risen its stake in Boston Properties Inc (NYSE:BXP).

Since February 7, 2018, it had 3 insider buys, and 2 selling transactions for $3.90 million activity. $99,815 worth of UGI Corporation (NYSE:UGI) was bought by Perreault Roger on Wednesday, February 7. $88 worth of UGI Corporation (NYSE:UGI) was bought by Kelly Ann P on Monday, April 2. Shares for $2.91M were sold by Sheridan Jerry E.

Investors sentiment decreased to 1.02 in Q4 2017. Its down 0.02, from 1.04 in 2017Q3. It dived, as 24 investors sold UGI shares while 127 reduced holdings. 53 funds opened positions while 101 raised stakes. 131.09 million shares or 0.40% less from 131.63 million shares in 2017Q3 were reported. Godshalk Welsh Capital Management Incorporated invested in 6,450 shares. Moreover, Zurcher Kantonalbank (Zurich Cantonalbank) has 0.01% invested in UGI Corporation (NYSE:UGI). Koch Inc owns 5,814 shares. Amp holds 231,470 shares. Wesbanco National Bank reported 0.04% of its portfolio in UGI Corporation (NYSE:UGI). Citadel Advsrs Ltd Com reported 45,403 shares or 0% of all its holdings. Mountain Pacific Investment Advisers Incorporated Id holds 1.56% of its portfolio in UGI Corporation (NYSE:UGI) for 316,795 shares. Clearbridge Lc has invested 0% of its portfolio in UGI Corporation (NYSE:UGI). Harvest Capital Management invested in 0.09% or 4,920 shares. 353,631 were reported by Legal & General Group Inc Public Ltd Company. Schwab Charles Invest reported 1.36M shares. Robeco Institutional Asset Mngmt Bv invested 0.03% in UGI Corporation (NYSE:UGI). Bnp Paribas Asset Mgmt Holding owns 21,723 shares. Brown Brothers Harriman And Commerce stated it has 0% in UGI Corporation (NYSE:UGI). Envestnet Asset Mgmt reported 0% of its portfolio in UGI Corporation (NYSE:UGI).

Among 5 analysts covering UGI Corp (NYSE:UGI), 1 have Buy rating, 1 Sell and 3 Hold. Therefore 20% are positive. UGI Corp had 15 analyst reports since August 5, 2015 according to SRatingsIntel. The stock of UGI Corporation (NYSE:UGI) earned “Buy” rating by Zacks on Saturday, August 8. As per Wednesday, August 5, the company rating was upgraded by Zacks. The rating was reinitiated by Janney Capital on Thursday, May 26 with “Neutral”. Jefferies maintained the stock with “Hold” rating in Monday, October 16 report. The firm has “Underweight” rating given on Monday, June 20 by Barclays Capital. The firm earned “Neutral” rating on Tuesday, March 27 by Citigroup. The stock of UGI Corporation (NYSE:UGI) has “Neutral” rating given on Wednesday, May 4 by Citigroup. The firm has “Hold” rating by Jefferies given on Wednesday, December 20. The rating was upgraded by UBS to “Buy” on Friday, April 20. The stock has “Underweight” rating by Barclays Capital on Friday, November 10.

Investors sentiment increased to 1.14 in Q4 2017. Its up 0.15, from 0.99 in 2017Q3. It improved, as 26 investors sold UTHR shares while 112 reduced holdings. 53 funds opened positions while 105 raised stakes. 40.90 million shares or 1.42% less from 41.49 million shares in 2017Q3 were reported. Mackenzie Fincl owns 0% invested in United Therapeutics Corporation (NASDAQ:UTHR) for 11,423 shares. Comerica Bank & Trust invested in 0.03% or 34,099 shares. Regions Corp reported 0% stake. Lazard Asset Mngmt Limited Liability Company owns 47 shares or 0% of their US portfolio. Schwab Charles Invest Mgmt stated it has 158,271 shares. Old Mutual Investors (Uk) reported 937,889 shares or 1.28% of all its holdings. Teacher Retirement Of Texas holds 0.01% in United Therapeutics Corporation (NASDAQ:UTHR) or 12,247 shares. Armistice Limited Co owns 200,000 shares for 2.95% of their portfolio. Hancock holds 0.06% or 9,023 shares. Kentucky-based Teachers Retirement System Of The State Of Kentucky has invested 0.02% in United Therapeutics Corporation (NASDAQ:UTHR). Northcoast Asset Mngmt Ltd Liability stated it has 0.17% in United Therapeutics Corporation (NASDAQ:UTHR). Parametrica Management invested in 0.34% or 3,611 shares. Allen Management Lc holds 0.04% in United Therapeutics Corporation (NASDAQ:UTHR) or 6,434 shares. Pinnacle Assocs Limited has 2,915 shares for 0.01% of their portfolio. Ftb Advsrs Inc invested 0% in United Therapeutics Corporation (NASDAQ:UTHR).

Guggenheim Capital Llc, which manages about $25.60B and $42.21B US Long portfolio, decreased its stake in Andeavor by 43,391 shares to 686,345 shares, valued at $78.48 million in 2017Q4, according to the filing. It also reduced its holding in Xperi Corp by 20,383 shares in the quarter, leaving it with 45,539 shares, and cut its stake in New Media Invt Group Inc (NYSE:NEWM).

More notable recent United Therapeutics Corporation (NASDAQ:UTHR) news were published by: Bizjournals.com which released: “Analysts: Generic drugs won’t affect United Therapeutics ‘that much'” on May 09, 2018, also Bizjournals.com with their article: “Md. biotech to be acquired by New Jersey pharmaceutical goliath” published on May 08, 2018, Nasdaq.com published: “Mid-Morning Market Update: Markets Open Higher; Sprint And T-Mobile To Merge In $26 Billion Deal” on April 30, 2018. More interesting news about United Therapeutics Corporation (NASDAQ:UTHR) were released by: Seekingalpha.com and their article: “MannKind Earnings On Deck – What To Look For” published on May 07, 2018 as well as Prnewswire.com‘s news article titled: “Stock Review for Drug Makers Investors — Endo, Ionis Pharma, Novo Nordisk, and United Therapeutics” with publication date: April 30, 2018.

Since March 14, 2018, it had 0 insider buys, and 10 selling transactions for $26.79 million activity.

United Therapeutics Corporation (NASDAQ:UTHR) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *